Research advances in necessity of antiviral therapy for chronic hepatitis B virus carriers
10.3760/cma.j.issn.1007-3418.2016.06.016
- VernacularTitle:慢性乙型肝炎病毒携带者抗病毒治疗必要性的研究进展
- Author:
Qin LONG
1
;
Yunqing YAO
;
Chengguo YAN
Author Information
1. 400016,重庆医科大学附属第一医院感染科
- Keywords:
Hepatitis B virus;
Antiviral agents;
Necessity
- From:
Chinese Journal of Hepatology
2016;24(6):465-468
- CountryChina
- Language:Chinese
-
Abstract:
Chronic hepatitis B virus (HBV) carriers are facing the risk of progression to liver fibrosis,liver cirrhosis,and hepatocellular carcinoma.However,due to low risk,slow disease progression,and unsatisfactory short-term effect of antiviral treatment,controversy still exists over whether such patients should be given antiviral treatment.This article reviews the research advances in the necessity and feasibility of antiviral therapy for chronic hepatitis B virus carriers,so as to provide a reference for clinical practice.
